Skip to main content
Top

2020 | OriginalPaper | Chapter

Analyzing the Immune Response of Neoepitopes for Personalized Vaccine Design

Authors : Iker Malaina, Leire Legarreta, Mª Dolores Boyano, Santos Alonso, Ildefonso M. De la Fuente, Luis Martinez

Published in: Bioinformatics and Biomedical Engineering

Publisher: Springer International Publishing

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

In the last few years, the importance of neoepitopes for the development of personalized antitumor vaccines has increased remarkably. This kind of epitopes are considered to generate a strong immune reaction, while their non-mutated version, which sometimes differs only in a single amino-acid, does not generate a response at all. In order to study if, regardless the immune tolerance, neoepitopes are quantitatively more immunogenic than the original strings, we have obtained samples of mutated and non-mutated epitopes of six patients with cutaneous melanoma in different stages, and then we have compared them. More precisely, we have used several bioinformatic tools to study certain properties of the epitopes such as the HLA binding affinity of classes I and II, and found that some of them are in fact increased in their mutated versions, which supports the hypothesis, and also reinforces the use of neoepitopes for cancer vaccine design.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Literature
3.
go back to reference Sahin, U., et al.: Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature 547, 7662 (2017)CrossRef Sahin, U., et al.: Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature 547, 7662 (2017)CrossRef
4.
go back to reference Kakimi, K., Karasaki, T., Matsushita, H., Sugie, T.: Advances in personalized cancer immunotherapy. Breast Cancer 24, 16–24 (2017)CrossRef Kakimi, K., Karasaki, T., Matsushita, H., Sugie, T.: Advances in personalized cancer immunotherapy. Breast Cancer 24, 16–24 (2017)CrossRef
5.
go back to reference Stratton, M.R.: Exploring the genomes of cancer cells: progress and promise. Science 331, 1553–1558 (2011)CrossRef Stratton, M.R.: Exploring the genomes of cancer cells: progress and promise. Science 331, 1553–1558 (2011)CrossRef
6.
go back to reference Kreiter, S., Castle, J.C., Türeci, Ö., Sahin, U.: Targeting the tumor mutanome for personalized vaccination therapy. Oncoimmunology 1, 768–769 (2012)CrossRef Kreiter, S., Castle, J.C., Türeci, Ö., Sahin, U.: Targeting the tumor mutanome for personalized vaccination therapy. Oncoimmunology 1, 768–769 (2012)CrossRef
7.
go back to reference Leclerc, M., et al.: Recent advances in lung cancer immunotherapy: input of T-cell epitopes associated with impaired peptide processing. Front. Immunol. 10, 1505 (2019)CrossRef Leclerc, M., et al.: Recent advances in lung cancer immunotherapy: input of T-cell epitopes associated with impaired peptide processing. Front. Immunol. 10, 1505 (2019)CrossRef
8.
go back to reference Vormehr, M., Türeci, Ö., Sahin, U.: Harnessing tumor mutations for truly individualized cancer vaccines. Annu. Rev. Med. 70, 395–407 (2019)CrossRef Vormehr, M., Türeci, Ö., Sahin, U.: Harnessing tumor mutations for truly individualized cancer vaccines. Annu. Rev. Med. 70, 395–407 (2019)CrossRef
9.
go back to reference Tanyi, J.L., et al.: Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer. Sci. Transl. Med. 10, eaao5931 (2018)CrossRef Tanyi, J.L., et al.: Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer. Sci. Transl. Med. 10, eaao5931 (2018)CrossRef
10.
go back to reference Hu, Z., Ott, P.A., Wu, C.J.: Towards personalized, tumour-specific, therapeutic vaccines for cancer. Nat. Rev. Immunol. 18, 168 (2018)CrossRef Hu, Z., Ott, P.A., Wu, C.J.: Towards personalized, tumour-specific, therapeutic vaccines for cancer. Nat. Rev. Immunol. 18, 168 (2018)CrossRef
11.
go back to reference Fritsch, E.F., Rajasagi, M., Ott, P.A., Brusic, V., Hacohen, N., Wu, C.J.: HLA-binding properties of tumor neoepitopes in humans. Cancer Immunol. Res. 2, 522–529 (2014)CrossRef Fritsch, E.F., Rajasagi, M., Ott, P.A., Brusic, V., Hacohen, N., Wu, C.J.: HLA-binding properties of tumor neoepitopes in humans. Cancer Immunol. Res. 2, 522–529 (2014)CrossRef
12.
go back to reference Lundegaard, C., Lund, O., Nielsen, M.: Prediction of epitopes using neural network-based methods. J. Immunol. Methods 374, 26–34 (2011)CrossRef Lundegaard, C., Lund, O., Nielsen, M.: Prediction of epitopes using neural network-based methods. J. Immunol. Methods 374, 26–34 (2011)CrossRef
13.
go back to reference Zhang, Q., et al.: Immune epitope database analysis resource (IEDB-AR). Nucl. Acids Res. 36, 513–518 (2008)CrossRef Zhang, Q., et al.: Immune epitope database analysis resource (IEDB-AR). Nucl. Acids Res. 36, 513–518 (2008)CrossRef
14.
go back to reference Soria-Guerra, R.E., Nieto-Gomez, R., Govea-Alonso, D.O., Rosales-Mendoza, S.: An overview of bioinformatics tools for epitope prediction: implications on vaccine development. J. Biomed. Inform. 53, 405–414 (2015)CrossRef Soria-Guerra, R.E., Nieto-Gomez, R., Govea-Alonso, D.O., Rosales-Mendoza, S.: An overview of bioinformatics tools for epitope prediction: implications on vaccine development. J. Biomed. Inform. 53, 405–414 (2015)CrossRef
15.
go back to reference Martínez, L., Milanič, M., Malaina, I., Álvarez, C., Pérez, M.B., Ildefonso, M.: Weighted lambda superstrings applied to vaccine design. PLoS ONE 14, e0211714 (2019)CrossRef Martínez, L., Milanič, M., Malaina, I., Álvarez, C., Pérez, M.B., Ildefonso, M.: Weighted lambda superstrings applied to vaccine design. PLoS ONE 14, e0211714 (2019)CrossRef
17.
18.
go back to reference Thompson, J.A.: The revised american joint committee on cancer staging system for melanoma. In: Seminars in Oncology, vol. 29, pp. 361–369. WB Saunders (2002) Thompson, J.A.: The revised american joint committee on cancer staging system for melanoma. In: Seminars in Oncology, vol. 29, pp. 361–369. WB Saunders (2002)
19.
go back to reference Edlundh-Rose, E., et al.: NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing. Melanoma Res. 16, 471–478 (2006)CrossRef Edlundh-Rose, E., et al.: NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing. Melanoma Res. 16, 471–478 (2006)CrossRef
20.
go back to reference Nikolaev, S.I., et al.: Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma. Nat. Genet. 44, 133 (2012)CrossRef Nikolaev, S.I., et al.: Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma. Nat. Genet. 44, 133 (2012)CrossRef
21.
go back to reference Ott, P.A., et al.: An immunogenic personal neoantigen vaccine for patients with melanoma. Nature 547, 217 (2017)CrossRef Ott, P.A., et al.: An immunogenic personal neoantigen vaccine for patients with melanoma. Nature 547, 217 (2017)CrossRef
22.
go back to reference Mann, E.R., Li, X.: Intestinal antigen-presenting cells in mucosal immune homeostasis: crosstalk between dendritic cells, macrophages and B-cells. World J. Gastroenterol. WJG 20, 9653 (2014)CrossRef Mann, E.R., Li, X.: Intestinal antigen-presenting cells in mucosal immune homeostasis: crosstalk between dendritic cells, macrophages and B-cells. World J. Gastroenterol. WJG 20, 9653 (2014)CrossRef
23.
go back to reference Trolle, T., et al.: The length distribution of class I–restricted T cell epitopes is determined by both peptide supply and MHC allele–specific binding preference. J. Immunol. 196, 1480–1487 (2016)CrossRef Trolle, T., et al.: The length distribution of class I–restricted T cell epitopes is determined by both peptide supply and MHC allele–specific binding preference. J. Immunol. 196, 1480–1487 (2016)CrossRef
24.
go back to reference López-Martínez, A., Chávez-Muñoz, C., Granados, J.: Función biológica del complejo principal de histocompatibilidad. Revista de investigación clínica 57, 132–141 (2005)PubMed López-Martínez, A., Chávez-Muñoz, C., Granados, J.: Función biológica del complejo principal de histocompatibilidad. Revista de investigación clínica 57, 132–141 (2005)PubMed
25.
go back to reference Sette, A., et al.: The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153, 5586–5592 (1994)PubMed Sette, A., et al.: The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153, 5586–5592 (1994)PubMed
26.
go back to reference Moutaftsi, M., et al.: A consensus epitope prediction approach identifies the breadth of murine T CD8 + -cell responses to vaccinia virus. Nat. Biotechnol. 24, 817 (2006)CrossRef Moutaftsi, M., et al.: A consensus epitope prediction approach identifies the breadth of murine T CD8 + -cell responses to vaccinia virus. Nat. Biotechnol. 24, 817 (2006)CrossRef
27.
go back to reference Kotturi, M.F., et al.: The CD8+ T-cell response to lymphocytic choriomeningitis virus involves the L antigen: uncovering new tricks for an old virus. J. Virol. 81, 4928–4940 (2007)CrossRef Kotturi, M.F., et al.: The CD8+ T-cell response to lymphocytic choriomeningitis virus involves the L antigen: uncovering new tricks for an old virus. J. Virol. 81, 4928–4940 (2007)CrossRef
Metadata
Title
Analyzing the Immune Response of Neoepitopes for Personalized Vaccine Design
Authors
Iker Malaina
Leire Legarreta
Mª Dolores Boyano
Santos Alonso
Ildefonso M. De la Fuente
Luis Martinez
Copyright Year
2020
DOI
https://doi.org/10.1007/978-3-030-45385-5_4

Premium Partner